Chaerunisaa Anis Yohana, Wardhana Yoga Windhu, Dewi Mayang Kusuma, Putri Margaretha Efa, Rahmania Fitriani Jati
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia.
Dosage Form Development Research Centre, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia.
Polymers (Basel). 2025 Jul 5;17(13):1879. doi: 10.3390/polym17131879.
Cellulose nanocrystals possess unique properties such as high surface area and excellent biocompatibility. They can disrupt strong hydrogen bonds and other intermolecular forces that hinder the solubility of certain molecules thus enhancing the solubility of poorly soluble materials. The main challenge in formulating poorly soluble drugs lies in their limited therapeutic efficacy due to inadequate solubility and bioavailability. Therefore, an innovative approach such as using cellulose nanocrystals to enhance the solubility is highly needed. The aim of this research is to study the potential of ramie ( L. Gaud) as a source of cellulose nanocrystals in the development of microspheres for the solubility enhancement of poorly soluble drugs. Nanocrystalline cellulose was isolated from the ramie ( L. Gaud) by optimizing hydrolysis conditions with varying acid concentrations and reaction times. Characterizations were performed by measuring particle size, pH, and sulfate content, followed by morphological study by SEM, functional group analysis, and thermal analysis. The use of sulfuric acid in the hydrolysis process of flax cellulose at 45 °C, as the type of acid that gives the best results, at 50% acid concentration for 60 min produces cellulose nanocrystallines with a particle size of 120 nm, sulfate concentration density of 133.09 mmol/kg, crystallinity of 96.2%, and a yield of 63.24 ± 8.72%. Furosemide was used as the poorly soluble drug model and its solubility enhancement in the form of furosemide/RNCC microspheres was evaluated through saturated solubility testing and in vitro dissolution. This study demonstrated that RNCC could improve the solubility of furosemide, which contributes to developing sustainable drug formulations and eco-friendly delivery systems for poorly soluble drugs.
纤维素纳米晶体具有独特的性质,如高比表面积和优异的生物相容性。它们可以破坏阻碍某些分子溶解的强氢键和其他分子间作用力,从而提高难溶性材料的溶解度。配制难溶性药物的主要挑战在于其溶解度和生物利用度不足导致治疗效果有限。因此,迫切需要一种创新方法,如使用纤维素纳米晶体来提高溶解度。本研究的目的是研究苎麻作为纤维素纳米晶体来源在开发用于提高难溶性药物溶解度的微球方面的潜力。通过优化不同酸浓度和反应时间的水解条件,从苎麻中分离出纳米晶纤维素。通过测量粒径、pH值和硫酸盐含量进行表征,随后通过扫描电子显微镜进行形态学研究、官能团分析和热分析。在45℃下,以硫酸作为亚麻纤维素水解过程中效果最佳的酸类型,在50%酸浓度下反应60分钟,可制备出粒径为120nm、硫酸盐浓度密度为133.09mmol/kg、结晶度为96.2%、产率为63.24±8.72%的纤维素纳米晶体。以呋塞米作为难溶性药物模型,通过饱和溶解度测试和体外溶出度评估其在呋塞米/RNCC微球形式下的溶解度提高情况。本研究表明,RNCC可以提高呋塞米的溶解度,这有助于为难溶性药物开发可持续的药物制剂和环保的给药系统。